Jim Simons’s Alpha Tau Medical DRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$286K Buy
+40,457
New +$286K ﹤0.01% 2805
2025
Q4
Sell
-61,900
Closed -$279K 3359
2025
Q3
$279K Buy
61,900
+32,500
+111% +$111K ﹤0.01% 3027
2025
Q2
$91.7K Buy
+29,400
New +$82.8K ﹤0.01% 3313
2025
Q1
Sell
-41,000
Closed -$127K 3542
2024
Q4
$127K Buy
41,000
+26,800
+189% +$68.6K ﹤0.01% 3249
2024
Q3
$33.8K Buy
+14,200
New +$31.4K ﹤0.01% 3386
2024
Q2
Sell
-14,700
Closed -$43K 3588
2024
Q1
$43K Sell
14,700
-9,900
-40% -$30.4K ﹤0.01% 3505
2023
Q4
$74K Buy
+24,600
New +$79.2K ﹤0.01% 3376
2022
Q4
Sell
-19,016
Closed -$111K 4166
2022
Q3
$111K Buy
+19,016
New +$168K ﹤0.01% 3558

Other funds holding DRTS

Jim Simons's DRTS Position: Q1 2026 in Review

Jim Simons opened a new position in Alpha Tau Medical (DRTS) in Q1 2026: 40,457 shares worth $286K. The stake represents ﹤0.01% of the portfolio and ranks #2805 among its holdings. This is a return to the name: Jim Simons previously reported a position in DRTS as recently as Q3 2025.

Jim Simons first reported a position in DRTS in Q3 2022 and has held it in 8 quarters since. 53 funds tracked by Wall St. Rank hold DRTS as of Q1 2026.

  • Jim Simons held 40,457 shares of Alpha Tau Medical worth $286K as of Q1 2026.
  • Alpha Tau Medical was a new Jim Simons position in Q1 2026.
  • Alpha Tau Medical made up ﹤0.01% of Jim Simons's portfolio in Q1 2026, its #2805 holding.
  • Jim Simons first reported a position in Alpha Tau Medical in Q3 2022 and has held it in 8 quarters since.
  • 53 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.